Brief: Oncocyte Strengthens Transplant Intellectual Property Portfolio With U.S. Patent
27/10/2021 13:13
Oct 27 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE STRENGTHENS TRANSPLANT INTELLECTUAL PROPERTY
PORTFOLIO
WITH US PATENT COVERING DIGITAL PCR TECHNOLOGY FOR EARLY
DETECTION OF ORGAN TRANSPLANT REJECTION
Source text for Eikon: ID:nGNX7M9HxG
Further company coverage: OCX.O
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission